Literature DB >> 31787853

Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes.

Jessica Stoll1,2, Sonia S Kupfer1,2.   

Abstract

A number of inherited syndromes affect the gastrointestinal tract, including Lynch syndrome and other hereditary colorectal cancers, hereditary polyposis, hereditary gastric cancer, hereditary pancreatic cancer, and hereditary pancreatitis. Recognition and diagnosis of these syndromes are paramount because affected individuals and family members can be offered life-saving screening, risk-reducing surgeries, and other therapies. Genetic counseling and testing are critical components of risk assessment and diagnosis of inherited syndromes. With the advent of next-generation sequencing, multigene panels have significantly changed the practice of genetic counseling and testing. Gastroenterology providers interface with patients who are at risk for inherited gastrointestinal syndromes; thus, providers should learn to recognize these syndromes and know when to refer their patients. Additionally, gastroenterology providers should have an understanding of genetic counseling and be able to interpret multigene panel test results. This article provides an overview of and practical tips for the assessment and diagnosis of hereditary gastrointestinal cancer syndromes and pancreatitis.
Copyright © 2019, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Genetic counseling; direct-to-consumer testing; genetic testing; hereditary gastrointestinal cancers; hereditary pancreatitis

Year:  2019        PMID: 31787853      PMCID: PMC6875877     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  56 in total

1.  Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?

Authors:  Susan M Domchek; Angela Bradbury; Judy E Garber; Kenneth Offit; Mark E Robson
Journal:  J Clin Oncol       Date:  2013-03-04       Impact factor: 44.544

2.  Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation.

Authors:  Frank Schwenter; Marie E Faughnan; Abigail B Gradinger; Terri Berk; Robert Gryfe; Aaron Pollett; Zane Cohen; Steven Gallinger; Carol Durno
Journal:  J Gastroenterol       Date:  2012-02-14       Impact factor: 7.527

3.  Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.

Authors:  Matthew B Yurgelun; Brian Allen; Rajesh R Kaldate; Karla R Bowles; Thaddeus Judkins; Praveen Kaushik; Benjamin B Roa; Richard J Wenstrup; Anne-Renee Hartman; Sapna Syngal
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

4.  ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Authors:  Colin C Pritchard; Christina Smith; Stephen J Salipante; Ming K Lee; Anne M Thornton; Alex S Nord; Cassandra Gulden; Sonia S Kupfer; Elizabeth M Swisher; Robin L Bennett; Akiva P Novetsky; Gail P Jarvik; Olufunmilayo I Olopade; Paul J Goodfellow; Mary-Claire King; Jonathan F Tait; Tom Walsh
Journal:  J Mol Diagn       Date:  2012-05-30       Impact factor: 5.568

5.  Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.

Authors:  Oliver M Sieber; Lara Lipton; Michael Crabtree; Karl Heinimann; Paulo Fidalgo; Robin K S Phillips; Marie-Luise Bisgaard; Torben F Orntoft; Lauri A Aaltonen; Shirley V Hodgson; Huw J W Thomas; Ian P M Tomlinson
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

Review 6.  The other colonic polyposis syndromes.

Authors:  Mark Omundsen; Francis F Lam
Journal:  ANZ J Surg       Date:  2012-08-21       Impact factor: 1.872

7.  An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.

Authors:  Ian J Majewski; Irma Kluijt; Annemieke Cats; Thomas S Scerri; Daphne de Jong; Roelof J C Kluin; Samantha Hansford; Frans B L Hogervorst; Astrid J Bosma; Ingrid Hofland; Marcel Winter; David Huntsman; Jos Jonkers; Melanie Bahlo; René Bernards
Journal:  J Pathol       Date:  2013-03       Impact factor: 7.996

8.  Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.

Authors:  Alison P Klein; Kieran A Brune; Gloria M Petersen; Michael Goggins; Anne C Tersmette; G Johan A Offerhaus; Constance Griffin; John L Cameron; Charles J Yeo; Scott Kern; Ralph H Hruban
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

9.  NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

Authors:  Janice L Berliner; Angela Musial Fay; Shelly A Cummings; Brittany Burnett; Todd Tillmanns
Journal:  J Genet Couns       Date:  2012-11-28       Impact factor: 2.537

10.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.

Authors:  Claire Palles; Jean-Baptiste Cazier; Kimberley M Howarth; Enric Domingo; Angela M Jones; Peter Broderick; Zoe Kemp; Sarah L Spain; Estrella Guarino; Estrella Guarino Almeida; Israel Salguero; Amy Sherborne; Daniel Chubb; Luis G Carvajal-Carmona; Yusanne Ma; Kulvinder Kaur; Sara Dobbins; Ella Barclay; Maggie Gorman; Lynn Martin; Michal B Kovac; Sean Humphray; Anneke Lucassen; Christopher C Holmes; David Bentley; Peter Donnelly; Jenny Taylor; Christos Petridis; Rebecca Roylance; Elinor J Sawyer; David J Kerr; Susan Clark; Jonathan Grimes; Stephen E Kearsey; Huw J W Thomas; Gilean McVean; Richard S Houlston; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330

View more
  3 in total

Review 1.  Multi-Gene Panel Testing in Gastroenterology: Are We Ready for the Results?

Authors:  Flávio Pereira; Manuel R Teixeira; Mário Dinis Ribeiro; Catarina Brandão
Journal:  GE Port J Gastroenterol       Date:  2021-02-04

Review 2.  How many is too many? Polyposis syndromes and what to do next.

Authors:  Nina Gupta; Christine Drogan; Sonia S Kupfer
Journal:  Curr Opin Gastroenterol       Date:  2022-01-01       Impact factor: 3.287

Review 3.  Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.

Authors:  Aaron J Grossberg; Linda C Chu; Christopher R Deig; Eliot K Fishman; William L Hwang; Anirban Maitra; Daniel L Marks; Arnav Mehta; Nima Nabavizadeh; Diane M Simeone; Colin D Weekes; Charles R Thomas
Journal:  CA Cancer J Clin       Date:  2020-07-19       Impact factor: 508.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.